Xwell (XWEL) Capital Expenditures Growth (3y) (2013 - 2026)
Xwell (XWEL) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -6.49% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -3.55% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 7.36% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 139.42% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -1.12% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.89% |
| 10 | Xwell | 7.40 Mn | -9.41 Mn | 2.35 Mn | 117.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.32% |
| Dec 31, 2025 | -33.55% |
| Sep 30, 2025 | 91.19% |
| Jun 30, 2025 | 64.94% |
| Mar 31, 2025 | -17.86% |
| Dec 31, 2024 | 2.96% |
| Sep 30, 2024 | -9.95% |
| Jun 30, 2024 | -52.21% |
| Mar 31, 2024 | -74.17% |
| Dec 31, 2023 | 25.21% |
| Sep 30, 2023 | -37.36% |
| Jun 30, 2023 | 16.30% |
| Mar 31, 2023 | -59.78% |
| Dec 31, 2022 | 110.01% |
| Sep 30, 2022 | -24.51% |
| Jun 30, 2022 | -63.27% |
| Mar 31, 2022 | 9.98% |
| Dec 31, 2021 | 57.77% |
| Sep 30, 2021 | -5.96% |
| Jun 30, 2021 | 31.90% |